Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Multicentre Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of AEB1102 in Patients With Arginase 1 Deficiency

NCT03378531 is registered in ClinicalTrials.gov with Immedica Pharma AB as lead sponsor.

NCT NCT03378531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03378531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Multicentre Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of AEB1102 in Patients With Arginase 1 Deficiency
Lead sponsor
Immedica Pharma AB
Phase
Phase 2
Overall status
Completed
Start date
December 7, 2017
Completion date
December 15, 2022
Enrollment
14 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

arginase i deficiency, hyperargininemia